SimonMed and Cox Business have entered into a partnership to introduce a new FDA-approved mammogram - tomosynthesis - to patients in the Arizona.
The tomosynthesis improves diagnostic accuracy over digital mammogram, increases breast cancer detection and reduces patient recall.
SimonMed founder John Simon said they are now able to increase the speed and accuracy with which they can share images, allowing all of their referring physicians to instantaneously double their productivity while decreasing the time it takes to make critical healthcare decisions.
Cox Business vice president Hyman Sukiennik said they are pleased to provide their network as the platform enabling SimonMed to revolutionize the way breast cancer is detected in the area.